News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,298 Results
Type
Article (45599)
Company Profile (373)
Press Release (663326)
Section
Business (207988)
Career Advice (2025)
Deals (35861)
Drug Delivery (101)
Drug Development (82653)
Employer Resources (171)
FDA (16472)
Job Trends (15236)
News (351823)
Policy (33545)
Tag
Academia (2714)
Alliances (50554)
Alzheimer's disease (1313)
Approvals (16428)
Artificial intelligence (172)
Bankruptcy (355)
Best Places to Work (11977)
Biotechnology (266)
Breast cancer (210)
Cancer (1552)
Cardiovascular disease (124)
Career advice (1687)
CAR-T (110)
Cell therapy (318)
Clinical research (66171)
Collaboration (585)
Compensation (316)
COVID-19 (2630)
C-suite (138)
Data (1482)
Diabetes (200)
Diagnostics (6333)
Earnings (85887)
Employer resources (149)
Events (113217)
Executive appointments (480)
FDA (17253)
Funding (524)
Gene therapy (231)
GLP-1 (664)
Government (4483)
Healthcare (19408)
Infectious disease (2729)
Inflammatory bowel disease (120)
Interviews (311)
IPO (16551)
Job creations (3714)
Job search strategy (1439)
Layoffs (439)
Legal (8122)
Lung cancer (226)
Manufacturing (224)
Medical device (13384)
Medtech (13389)
Mergers & acquisitions (19567)
Metabolic disorders (521)
Neuroscience (1684)
NextGen: Class of 2025 (6730)
Non-profit (4629)
Northern California (1878)
Obesity (302)
Opinion (198)
Patents (134)
People (58061)
Phase I (20586)
Phase II (29021)
Phase III (21752)
Pipeline (617)
Postmarket research (2734)
Preclinical (8814)
Radiopharmaceuticals (248)
Rare diseases (298)
Real estate (6055)
Regulatory (22529)
Research institute (2447)
Resumes & cover letters (352)
Southern California (1623)
Startups (3698)
United States (16919)
Vaccines (598)
Weight loss (216)
Date
Today (27)
Last 7 days (467)
Last 30 days (1886)
Last 365 days (35668)
2025 (1629)
2024 (36093)
2023 (40891)
2022 (52085)
2021 (56670)
2020 (55113)
2019 (47755)
2018 (36036)
2017 (32944)
2016 (32528)
2015 (38573)
2014 (32268)
2013 (27581)
2012 (29728)
2011 (30285)
2010 (28309)
Location
Africa (763)
Arizona (208)
Asia (38928)
Australia (6401)
California (4290)
Canada (1557)
China (366)
Colorado (196)
Connecticut (213)
Europe (84544)
Florida (605)
Georgia (153)
Illinois (432)
Indiana (244)
Maryland (694)
Massachusetts (3370)
Michigan (184)
Minnesota (323)
New Jersey (1209)
New York (1218)
North Carolina (824)
Northern California (1878)
Ohio (152)
Pennsylvania (1002)
South America (1123)
Southern California (1623)
Texas (618)
Utah (120)
Washington State (440)
709,298 Results for "chroma medicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology
Chroma Medicine, Inc. (Chroma) a genomic medicine company pioneering single-course epigenetic editing therapeutics, today announced it has entered into an exclusive license agreement with the Whitehead Institute to access intellectual property and technology developed in the lab of Chroma co-founder Jonathan Weissman, Ph.D.
June 27, 2024
·
2 min read
Business
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
Chroma Medicine, Inc. today announced the appointment of Jenny Marlowe, Ph.D., as the Company’s Chief Development Officer.
May 20, 2024
·
2 min read
Press Releases
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
December 11, 2024
·
5 min read
Business
Chroma Medicine Demonstrates Robust and Durable HBV Silencing with CRMA-1001 at 2024 International HBV Meeting
September 16, 2024
·
3 min read
Press Releases
Chroma Medicine Appoints Renowned RNA Scientist Melissa Moore to Board of Directors
July 19, 2024
·
2 min read
Business
Chroma Medicine Strengthens Leadership with the Appointment of Biotech Business Leader Michael A. Kelly to its Board of Directors
Chroma Medicine, Inc. announced the addition of innovative biotech business leader Michael A. Kelly to its Board of Directors.
September 27, 2023
·
2 min read
Genetown
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Chroma Medicine, Inc. presented data demonstrating the potential of its multiplex epigenetic editing platform to enhance functional allogeneic chimeric antigen receptor T cells at the American Society of Hematology 65th Annual Meeting in San Diego.
December 10, 2023
·
3 min read
Genetown
Chroma Medicine to Showcase Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Chroma Medicine, Inc. announced that it will present a poster demonstrating the potential of its multiplex epigenetic editing platform at the American Society of Hematology 65th Annual Meeting, taking place December 9-12, 2023, in San Diego, CA.
November 2, 2023
·
1 min read
Press Releases
Chroma Medicine Presents Preclinical In Vivo Data Demonstrating Best-in-Class Potency and Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2024 ESC Congress
September 3, 2024
·
4 min read
Drug Development
Chroma Medicine Presents Preclinical In Vivo Data Showing Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2023 AHA Scientific Sessions
Chroma Medicine, Inc. presented new preclinical data demonstrating that a single administration of its epigenetic editor efficiently and durably lowered PCSK9 and cholesterol levels in non-human primates in a late-breaking oral presentation at the 2023 American Heart Association Scientific Sessions, held November 11-13 in Philadelphia.
November 11, 2023
·
5 min read
1 of 70,930
Next
